Two hours with a named specialist, on whatever you need to work through. The low-risk way to start.
£750 per session
Learn more →Ongoing access to the team, structured around your specific needs rather than a fixed package.
An independent read on what is blocking your revenue and scale in healthcare. Not a report that sits on a shelf.
Thirty years between us building and selling health technology, and practising in the system that buys it. Lived, not theoretical.
CEO
Strategy, partnerships, and market positioning across the UK and Middle East health-innovation ecosystem.
COO
Commercial strategy, healthcare procurement, and primary-care pathway development. NICE committee member.
CPO
Product assessment, medical-device regulation, compliance, and quality management systems.
Thanks to Collider's hard work and expertise, we were able to launch our pilot phase on schedule with high-quality, well-aligned sites.
Taha · Founder, Mindbay.ai
The Health Collider team were great to work with, easygoing, really supportive, and helped us connect with innovative healthcare providers genuinely open to doing things differently.
Nara · Founder, PAL Helps
Clinical safety, data protection and cyber compliance
A UK compliance platform for health tech. We send them companies who need a regulatory and compliance base before market access is worth pursuing; they send us companies who are compliant and funded but stalled on getting sold.
Health-tech events and international delegations
Europe's health innovation event series. We support their international delegations with context on how the UK healthcare system actually buys, before they arrive.
It turns on three things: a payer with budget, someone who can sign, and a proposition that reads as best practice rather than disruption. Most founders solve one and assume the rest follow.
Most advisors sell one slice - compliance here, sales there, nobody joining them up. We cover clinical, commercial and regulatory as one team, and we are on the buyer's side of the table in our day jobs.
Maps how money reaches your product, identifies who decides, and positions it so healthcare buyers can say yes. For us that also means routes into ICBs and PCNs, and a clinician community that can supply pilot sites and case studies.
A session summary lands within five working days, a full assessment in four to six weeks. Scope and dates are agreed in writing first.
30 minutes, no deck required. We respond within 2 working days.
Book an intro call